← Back to Analyst Consensus 
KPTI Buy
Karyopharm Therapeutics Inc.
Current Price —
Implied Upside —
Analysts 11
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Oct 29, 2026 (3 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Jul 31, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Jul 31, 2026 | HC Wainwright & Co. | downgrade | Buy → Neutral | — | 44% |
| May 6, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Apr 27, 2026 | Piper Sandler | reiterate | Overweight → Overweight | — | 54% |
| Mar 30, 2026 | Piper Sandler | reiterate | Overweight → Overweight | — | 54% |
| Mar 25, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| Mar 25, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Mar 10, 2026 | Rodman & Renshaw | initiate | — → Buy | — | 40% |
| Feb 18, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Feb 5, 2026 | Cantor Fitzgerald | initiate | — → Overweight | $0 | 50% |
| Nov 4, 2025 | RBC Capital | maintain | Outperform → Outperform | $19 | 55% |
| Oct 13, 2025 | HC Wainwright & Co. | upgrade | Neutral → Buy | $15 | 44% |
| Oct 9, 2025 | Piper Sandler | reiterate | Overweight → Overweight | $12 | 54% |
| Oct 9, 2025 | Baird | maintain | Outperform → Outperform | $21 | 55% |
| Aug 12, 2025 | Baird | maintain | Outperform → Outperform | $25 | 55% |
| Jul 16, 2025 | HC Wainwright & Co. | downgrade | Buy → Neutral | $0 | 44% |
| May 13, 2025 | RBC Capital | maintain | Outperform → Outperform | $33 | 55% |
| May 13, 2025 | Barclays | maintain | Overweight → Overweight | $10 | 53% |
| May 13, 2025 | Baird | maintain | Outperform → Outperform | $42 | 55% |
| Mar 3, 2025 | Baird | maintain | Outperform → Outperform | $54 | 55% |
| Feb 26, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $56 | 44% |
| Feb 20, 2025 | RBC Capital | reiterate | Outperform → Outperform | $3 | 55% |
| Feb 20, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Feb 10, 2025 | RBC Capital | reiterate | Outperform → Outperform | $3 | 55% |
| Jan 15, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Nov 6, 2024 | Piper Sandler | maintain | Overweight → Overweight | $5 | 54% |
| Nov 6, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Nov 1, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Aug 7, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Aug 7, 2024 | RBC Capital | reiterate | Outperform → Outperform | $3 | 55% |
| Aug 7, 2024 | Baird | maintain | Outperform → Outperform | $5 | 55% |
| Jun 28, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $7 | 44% |
| Jun 3, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| May 9, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| Mar 1, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $8 | 44% |
| Nov 3, 2023 | Piper Sandler | maintain | Overweight → Overweight | $5 | 54% |
| Nov 3, 2023 | RBC Capital | maintain | Outperform → Outperform | $3 | 55% |
| Aug 7, 2023 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $4 | 54% |
| Aug 3, 2023 | Piper Sandler | maintain | Overweight → Overweight | $7 | 54% |
| Aug 3, 2023 | RBC Capital | maintain | Outperform → Outperform | $4 | 55% |
| Aug 3, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Jul 26, 2023 | Wedbush | maintain | Neutral → Neutral | $4 | 58% |
| Jul 26, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Jul 18, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| May 5, 2023 | RBC Capital | maintain | — → Outperform | $5 | 55% |
| May 5, 2023 | HC Wainwright & Co. | maintain | — → Buy | $10 | 44% |
| May 5, 2023 | Baird | maintain | — → Outperform | $10 | 55% |
| Apr 19, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $16 | 44% |
| Feb 22, 2023 | HC Wainwright & Co. | maintain | — → Buy | $16 | 44% |
| Feb 16, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $16 | 44% |
Price Target Trend
May 14, 2026 Latest: $7.25 Oct 25, 2026
EPS Estimates
0q $-1.31
Lo: $-1.37 Hi: $-1.26
2 analysts ▲2
0y $-5.84
Lo: $-6.01 Hi: $-5.68
2 analysts ▲1
+1q $-1.21
Lo: $-1.30 Hi: $-1.12
2 analysts ▲1
+1y $-2.82
Lo: $-3.72 Hi: $-1.92
2 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days